CDH2 and prostate cancer: Previous study has reported that N-cadherin is highly expressed in various cancer, including lung cancer, breast cancer, prostate cancer and squamous cell carcinoma, and abnormal expression of N-cadherin is associated with tumor aggressiveness [32].